Squarepoint
SGHT icon

Squarepoint’s Sight Sciences SGHT Stock Holding History

Squarepoint’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
331,754
+291,079
+716% +$1.57M ﹤0.01% 2584
2025
Q4 		$323K Buy
+40,675
New +$260K ﹤0.01% 3546
2025
Q2 		– Sell
-166,405
Closed -$399K – 4990
2025
Q1 		$399K Sell
166,405
-2,806
-2% -$7.9K ﹤0.01% 3500
2024
Q4 		$616K Buy
169,211
+128,355
+314% +$585K ﹤0.01% 3542
2024
Q3 		$257K Buy
40,856
+27,697
+210% +$186K ﹤0.01% 3553
2024
Q2 		$87.8K Sell
13,159
-41,809
-76% -$247K ﹤0.01% 3819
2024
Q1 		$290K Sell
54,968
-89,695
-62% -$422K ﹤0.01% 3414
2023
Q4 		$746K Buy
144,663
+24,575
+20% +$75.8K ﹤0.01% 2729
2023
Q3 		$405K Buy
120,088
+90,981
+313% +$598K ﹤0.01% 2946
2023
Q2 		$241K Buy
29,107
+18,029
+163% +$162K ﹤0.01% 3101
2023
Q1 		$96.8K Buy
+11,078
New +$123K ﹤0.01% 2976
2022
Q3 		– Sell
-21,778
Closed -$196K – 3386
2022
Q2 		$196K Buy
+21,778
New +$192K ﹤0.01% 2489

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Squarepoint's SGHT Position: Q1 2026 in Review

Squarepoint increased its Sight Sciences (SGHT) stake by 716% in Q1 2026, buying an estimated $1.57M and bringing the position to 331,754 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

Squarepoint first reported a position in SGHT in Q2 2022 and has held it in 12 quarters since. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Squarepoint held 331,754 shares of Sight Sciences worth $1.25M as of Q1 2026.
  • Squarepoint bought 291,079 Sight Sciences shares in Q1 2026, an estimated $1.57M.
  • Sight Sciences made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2584 holding.
  • Squarepoint first reported a position in Sight Sciences in Q2 2022 and has held it in 12 quarters since.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.